Novel bifunctional molecules described in this review build on this anti-inflammatory action and will have the capacity to impact multiple factors including blood pressure, lipid and triglyceride levels, and insulin signaling in metabolic diseases like MetS, type 2 diabetes and NAFLD. The gene discussed is INS; the disease is type 2 diabetes mellitus.